ELOXX PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 169.30 thousand shares for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 169.30K shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 25.50K shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 0.00 shares.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 86.11K shares, a 98.68% decline from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 6.50M shares, a 364.53% increase from fiscal 2020.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 1.40M shares, a 24.04% decline from fiscal 2019.
- ELOXX PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 1.84M shares, a 7.66% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 169.30K shares derived: S-1 6 month − 10-Q 3 month · filed 2026-09-11 | 169.30K shares S-1 · filed 2026-09-11 | ||||||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 894.36K shares S-1 · filed 2026-09-11 | 9.84M shares 10-K · filed 2026-03-17 | ||||||
| 2024-12-31 | 0.00 shares S-1 · filed 2026-09-11 | |||||||
| 2023-09-30 | 25.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 25.50K shares derived: sum of 2 quarters · filed 2023-11-13 | 221.40K shares 10-Q · filed 2023-11-13 | -2.96M shares derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 195.90K shares 10-Q · filed 2023-08-11 | -2.99M shares derived: sum of 3 quarters · filed 2023-08-11 | -2.99M shares derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2023-03-31 | 195.90K shares 10-Q · filed 2023-05-12 | -2.99M shares derived: sum of 2 quarters · filed 2023-05-12 | -2.99M shares derived: sum of 3 quarters · filed 2023-05-12 | -2.99M shares derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2022-12-31 | -3.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -3.18M shares derived: sum of 2 quarters · filed 2023-03-31 | -3.18M shares derived: sum of 3 quarters · filed 2023-03-31 | 86.11K shares 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-10 | 3.27M shares 10-Q · filed 2022-11-10 | 4.04M shares derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 3.27M shares 10-Q · filed 2022-08-12 | 4.04M shares derived: sum of 3 quarters · filed 2022-08-12 | 5.11M shares derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2022-03-31 | 3.27M shares 10-Q · filed 2022-05-06 | 4.04M shares derived: sum of 2 quarters · filed 2022-05-06 | 5.11M shares derived: sum of 3 quarters · filed 2022-05-06 | 9.10M shares derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2021-12-31 | 771.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 1.84M shares derived: sum of 2 quarters · filed 2022-03-30 | 5.83M shares derived: sum of 3 quarters · filed 2022-03-30 | 6.50M shares 10-K · filed 2022-03-30 | ||||
| 2021-09-30 | 1.07M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 5.05M shares derived: sum of 2 quarters · filed 2021-11-08 | 5.73M shares 10-Q · filed 2021-11-08 | 5.73M shares derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2021-06-30 | 3.99M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 4.66M shares 10-Q · filed 2021-08-16 | 4.66M shares derived: sum of 3 quarters · filed 2021-08-16 | 4.70M shares derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2021-03-31 | 677.73K shares 10-Q · filed 2021-05-07 | 677.73K shares derived: sum of 2 quarters · filed 2021-05-07 | 716.83K shares derived: sum of 3 quarters · filed 2021-05-07 | 890.93K shares derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 39.10K shares derived: sum of 2 quarters · filed 2021-03-12 | 213.20K shares derived: sum of 3 quarters · filed 2021-03-12 | 1.40M shares 10-K · filed 2021-03-12 | ||||
| 2020-09-30 | 39.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 213.20K shares derived: sum of 2 quarters · filed 2020-11-06 | 1.40M shares 10-Q · filed 2020-11-06 | 1.46M shares derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2020-06-30 | 174.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 1.36M shares 10-Q · filed 2020-08-07 | 1.42M shares derived: sum of 3 quarters · filed 2020-08-07 | 2.08M shares derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2020-03-31 | 1.19M shares 10-Q · filed 2020-05-08 | 1.25M shares derived: sum of 2 quarters · filed 2020-05-08 | 1.91M shares derived: sum of 3 quarters · filed 2020-05-08 | 2.23M shares derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2019-12-31 | 62.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | 719.09K shares derived: sum of 2 quarters · filed 2020-03-06 | 1.04M shares derived: sum of 3 quarters · filed 2020-03-06 | 1.84M shares 10-K · filed 2020-03-06 | ||||
| 2019-09-30 | 656.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 976.10K shares derived: sum of 2 quarters · filed 2019-11-06 | 1.78M shares 10-Q · filed 2019-11-06 | 1.85M shares derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2019-06-30 | 319.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 1.12M shares 10-Q · filed 2019-08-07 | 1.20M shares derived: sum of 3 quarters · filed 2019-08-07 | 2.10M shares derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2019-03-31 | 804.10K shares 10-Q · filed 2019-05-09 | 878.60K shares derived: sum of 2 quarters · filed 2019-05-09 | 1.78M shares derived: sum of 3 quarters · filed 2019-05-09 | 1.78M shares derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2018-12-31 | 74.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 979.67K shares derived: sum of 2 quarters · filed 2019-03-14 | 979.67K shares derived: sum of 3 quarters · filed 2019-03-14 | 1.71M shares 10-K · filed 2019-03-14 | ||||
| 2018-09-30 | 905.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 905.17K shares derived: sum of 2 quarters · filed 2018-11-08 | 1.64M shares 10-Q · filed 2018-11-08 | |||||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 732.21K shares 10-Q · filed 2018-08-10 | ||||||
| 2018-03-31 | 732.21K shares 10-Q · filed 2018-05-10 | |||||||
| 2017-06-30 | 436.36K shares 10-K · filed 2017-10-13 | |||||||
| 2016-06-30 | 330.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | 330.68K shares derived: sum of 2 quarters · filed 2016-10-13 | 485.68K shares 10-K · filed 2016-10-13 | |||||
| 2016-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | 155.00K shares 10-Q · filed 2016-05-12 | ||||||
| 2015-12-31 | 155.00K shares 10-Q · filed 2016-02-16 | |||||||
| 2015-06-30 | 432.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | 959.19K shares derived: sum of 2 quarters · filed 2015-10-09 | 1.20M shares 10-K · filed 2015-10-09 | |||||
| 2015-03-31 | 526.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | 771.34K shares 10-Q · filed 2015-05-14 | ||||||
| 2014-12-31 | 244.48K shares 10-Q · filed 2015-02-17 | |||||||
| 2014-11-18 | 392.86K shares 10-K · filed 2017-10-13 | |||||||
| 2014-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | 46.78K shares 10-Q · filed 2014-05-09 | ||||||
| 2013-12-31 | 46.78K shares 10-Q · filed 2014-02-14 | |||||||
| 2013-09-30 | 46.78K shares 10-K · filed 2014-09-29 | |||||||
| 2013-09-13 | 46.78K shares 10-K · filed 2016-10-13 | |||||||
| 2012-11-16 | 3.71M shares 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |